Deccanprince Biotech & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 10-12-2024
- Revenue 47.81%
(FY 2021)
- Profit 341.27%
(FY 2021)
- Ebitda 54.46%
(FY 2021)
- Net Worth 94.91%
(FY 2021)
- Total Assets 31.43%
(FY 2021)
About Deccanprince Biotech & Chemicals
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Sunil Mali and Anil Mali serve as directors at the Company.
- CIN/LLPIN
U24120MH2008PTC183118
- Company No.
183118
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deccanprince Biotech & Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Mali  | Director | 03-Jun-2008 | Current |
| Anil Mali | Director | 03-Jun-2008 | Current |
Financial Performance of Deccanprince Biotech & Chemicals.
Deccanprince Biotech & Chemicals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 47.81% increase. The company also saw a substantial improvement in profitability, with a 341.27% increase in profit. The company's net worth Soared by an impressive increase of 94.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deccanprince Biotech & Chemicals?
In 2021, Deccanprince Biotech & Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 17 Mar 2010 | ₹1.50 M | Open |
How Many Employees Work at Deccanprince Biotech & Chemicals?
Unlock and access historical data on people associated with Deccanprince Biotech & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deccanprince Biotech & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deccanprince Biotech & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
